GlassScriptPhysician profile
Elizabeth S Lambert
NPI 1295868685
$1,341.11
in general payments reported to CMS, 2019-2025
29 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2022: $462 · 2023: $315 · 2024: $171 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $199.56 | 2022-2025 | Slynd |
| Abbvie INC. | $152.83 | 2019-2023 | |
| Daiichi Sankyo INC. | $129.05 | 2022-2024 | Injectafer |
| Pfizer INC. | $122.81 | 2019-2023 | |
| Channel Medsystems, INC. | $92.58 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $72.48 | 2023-2024 | Myfembree, Gemtesa |
| Agile Therapeutics, INC. | $50.66 | 2022-2023 | Twirla |
| Applied Medical Resources Corporation | $48.84 | 2023 | Gelpoint V-Path |
| Therapeuticsmd, INC. | $39.18 | 2022 | |
| Medtronic, INC. | $38.87 | 2023 | Ligasure |
| Myovant Sciences INC. | $34.70 | 2022 | |
| Tris Pharma INC | $32.51 | 2019 | |
| Mayne Pharma Commercial LLC | $28.67 | 2025 | |
| Scynexis, INC. | $26.95 | 2022 | |
| Amag Pharmaceuticals, INC. | $26.21 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $24.48 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.78 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.74 | 2022 | |
| Emd Serono, INC. | $21.76 | 2019 | |
| Exact Sciences Corporation | $19.66 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $18.96 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $18.72 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Astellas Pharma US INC | $17.77 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.05 | 2024 | Xifaxan |
| Neos Therapeutics, LP | $14.92 | 2019 | |
| Avion Pharmaceuticals | $12.96 | 2019 | |
| Merck Sharp & Dohme LLC | $11.76 | 2019 | |
| Allergan, INC. | $11.57 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.